PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
BTK 1,263 Target Disease Leukemia 162,805 104 0.01 -0.96 0.08 0.61
Chorismate Synthase 85 Target Disease Tuberculosis 146,217 7 0.00 -0.96 0.08 0.58
Arachidonate 5-Lipoxygenase 170 Target Disease Inflammation 252,734 14 0.00 -0.96 0.08 0.58
Calmodulin 25,240 Target Target Glutamate Receptor 1 352 29 0.01 -0.96 0.08 0.65
Collagen 138,882 Target Target Proteinase-Activated Receptor 1 133 11 0.00 -0.96 0.08 0.59
CXCL11 526 Target Target CXCL3 145 12 0.04 -0.95 0.08 0.78
CCL4 5,638 Target Target CCL2 3,560 295 0.07 -0.93 0.08 0.78
CD22 1,591 Target Drug Arranon (Nelarabine)- FDA 12 1 0.01 -0.96 0.08 0.68
CD4 112,219 Target Drug Arranon (Nelarabine)- FDA 12 1 0.00 -0.96 0.08 0.58
CD4 112,219 Target Disease Leprosy Lepromatous 12 1 0.00 -0.96 0.08 0.58
Cysteinyl Leukotriene Receptor 2 24 Target Target ERK1 18,374 2 0.00 -0.96 0.08 0.63
APOE 12,771 Target Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.63
Carbonic Anhydrase 3 36 Target Disease Inflammation 252,734 3 0.00 -0.96 0.08 0.57
Ent2 108 Target Disease Leukemia 162,805 9 0.00 -0.96 0.08 0.58
CCL7 274 Target Target Eotaxin 2,457 23 0.03 -0.95 0.08 0.73
Antithrombin 13,773 Target Target Bivalirudin 891 75 0.02 -0.95 0.08 0.69
Collagenase-3 367 Target Disease Inflammation 252,734 31 0.00 -0.96 0.08 0.58
Collagenase 3 367 Target Disease Inflammation 252,734 31 0.00 -0.96 0.08 0.58
Androgen Receptor 12,918 Target Target Estrogen Receptor Beta 1,924 163 0.03 -0.95 0.08 0.71
Beta-Secretase 1 59 Target Disease Dementia 66,782 5 0.00 -0.96 0.08 0.60
EPHA4 357 Target Target EPHB3 118 10 0.05 -0.94 0.08 0.79
Collagen 138,882 Target Target bFGF 9,327 791 0.02 -0.95 0.08 0.64
CD68 6,424 Target Target CD34 24,598 546 0.04 -0.95 0.08 0.72
CXCL16 341 Target Target CCL2 3,560 29 0.03 -0.95 0.09 0.72
ApoE2 517 Target Disease Hyperlipoproteinemia 2,954 44 0.04 -0.95 0.09 0.74
Myeloperoxidase 16,181 Target Target Cathepsin G 1,613 138 0.03 -0.95 0.09 0.70
ANXA7 35 Target Disease Carcinoma 433,099 3 0.00 -0.96 0.09 0.56
ANXA7 35 Target Disease Brain Tumors 16,749 3 0.00 -0.96 0.09 0.63
D4-GDI 35 Target Disease Infection 766,637 3 0.00 -0.96 0.09 0.54
Glutathione S-Transferase Theta-1 70 Target Disease Leukemia 162,805 6 0.00 -0.96 0.09 0.58
BAFF 1,240 Target Disease Arthritis 128,324 107 0.01 -0.96 0.09 0.61
CD4 112,219 Target Target CCL8 197 17 0.00 -0.96 0.09 0.60
CXCL11 526 Target Target CCL8 197 17 0.05 -0.94 0.09 0.79
ANGPT1 81 Target Disease Inflammation 252,734 7 0.00 -0.96 0.09 0.57
Angiotensin Converting Enzyme 31,674 Target Disease Diabetic Nephropathy 12,496 1,080 0.05 -0.94 0.09 0.73
CD4 112,219 Target Drug Aptivus (Tipranavir)- FDA 23 2 0.00 -0.96 0.09 0.58
ACVR1B 23 Target Target BMPR1A 279 2 0.02 -0.95 0.09 0.76
ACVR1B 23 Target Disease Lung Cancer 91,416 2 0.00 -0.96 0.09 0.59
Alpha-Glucosidase 4,319 Target Target Alpha-Amylase 7,171 376 0.07 -0.93 0.09 0.77
APOC1 126 Target Disease Inflammation 252,734 11 0.00 -0.96 0.09 0.57
CCNB1 160 Target Disease Breast Cancer 173,695 14 0.00 -0.96 0.09 0.59
CCL7 274 Target Disease Cancer 1,053,491 24 0.00 -0.96 0.09 0.55
CCL7 274 Target Target CXCL9 1,016 24 0.05 -0.94 0.09 0.77
EPHA2 532 Target Target EPHB1 137 12 0.04 -0.94 0.09 0.78
CD1A 2,739 Target Disease Infection 766,637 240 0.01 -0.96 0.09 0.57
CCL4 5,638 Target Target CXCL10/IP-10 114 10 0.01 -0.95 0.09 0.68
ACRP30 102 Target Disease Cholesterol 182,390 9 0.00 -0.95 0.09 0.58
CXCL7 76 Target Target CCL14 34 3 0.06 -0.94 0.09 0.82
CD4 112,219 Target Target CCL3 1,427 127 0.01 -0.95 0.09 0.62
Collagenase-3 367 Target Disease Osteoarthritis 36,287 33 0.01 -0.95 0.09 0.64
ANGPTL4 289 Target Disease Cholesterol 182,390 26 0.00 -0.95 0.09 0.59
CCL4 5,638 Target Target CXCL2 750 68 0.03 -0.95 0.09 0.73
CKMM 55 Target Target CKBB 57 5 0.09 -0.91 0.09 0.86
Glucocorticoid Receptor 10,306 Target Drug Aphrodyne (Yohimbine)- FDA 11 1 0.00 -0.95 0.09 0.63
CD4 112,219 Target Drug Atovaquone (Mepron)- FDA 11 1 0.00 -0.95 0.09 0.58
744.1 22 Target Disease Cardiac Arrest 20,700 2 0.00 -0.95 0.09 0.62
744.1 22 Target Disease Inflammation 252,734 2 0.00 -0.95 0.09 0.57
744.1 22 Target Disease Heart Disease 118,291 2 0.00 -0.95 0.09 0.58
CEA 17,022 Target Drug Aphrodyne (Yohimbine)- FDA 11 1 0.00 -0.95 0.09 0.62
BAFFR 44 Target Disease Rheumatoid Arthritis 78,952 4 0.00 -0.95 0.09 0.60
Atosiban 274 Target Drug Atropine (Atropen)- FDA 11 1 0.02 -0.95 0.09 0.74
Atosiban 274 Target Drug Atropen (Atropine)- FDA 11 1 0.02 -0.95 0.09 0.74
ACAD8 11 Target Disease Prostate Cancer 71,064 1 0.00 -0.95 0.09 0.59
ACAD8 11 Target Disease Dehydration 21,928 1 0.00 -0.95 0.09 0.62
ACAD8 11 Target Disease Anemia 81,663 1 0.00 -0.95 0.09 0.59
ACAD8 11 Target Target APOE 12,771 1 0.00 -0.95 0.09 0.63
ACAD8 11 Target Disease Cholesterol 182,390 1 0.00 -0.95 0.09 0.57
Neuropeptide S Receptor 77 Target Disease Inflammation 252,734 7 0.00 -0.95 0.09 0.57
DC-CK1 22 Target Disease Arthritis 128,324 2 0.00 -0.95 0.09 0.58
DC-CK1 22 Target Disease Rheumatoid Arthritis 78,952 2 0.00 -0.95 0.09 0.59
DC-CK1 22 Target Disease Inflammation 252,734 2 0.00 -0.95 0.09 0.57
ADSF 11 Target Target D-Dimer 6,185 1 0.00 -0.95 0.09 0.65
ADSF 11 Target Disease Seizures 66,465 1 0.00 -0.95 0.09 0.59
ERK1 18,374 Target Target DEP-1 88 8 0.01 -0.95 0.09 0.64
Metabotropic Glutamate Receptor 3 55 Target Disease Pain 409,851 5 0.00 -0.95 0.09 0.56
CD34 24,598 Target Disease Myeloma Multiple 11 1 0.00 -0.95 0.09 0.61
A1AT 329 Target Disease Liver Disease 49,817 30 0.01 -0.95 0.09 0.63
CCL2 3,560 Target Target CXCL11 526 48 0.04 -0.95 0.09 0.74
AFP 9,751 Target Target Chorionic Gonadotropin beta 936 86 0.03 -0.95 0.09 0.71
CXCL7 76 Target Target CCL3 1,427 7 0.02 -0.95 0.09 0.73
CXCL7 76 Target Target CCL8 197 7 0.06 -0.94 0.09 0.81
Artemin 184 Target Disease Carcinoma 433,099 17 0.00 -0.95 0.09 0.57
Phosphodiesterase 4b 54 Target Disease Cancer 1,053,491 5 0.00 -0.95 0.09 0.54
Aldosterone Receptor 528 Target Target Collagen 138,882 49 0.01 -0.95 0.09 0.60
EPHA2 532 Target Target EPHA3 140 13 0.05 -0.94 0.09 0.78
CAMK4 43 Target Disease Inflammation 252,734 4 0.00 -0.95 0.09 0.57
Insulin-Like Growth Factor 1 Receptor 1,052 Target Disease Breast Cancer 173,695 98 0.01 -0.95 0.09 0.61
Acetyl-Coa Carboxylase 1 118 Target Disease Liver Disease 49,817 11 0.00 -0.95 0.09 0.62
CEA 17,022 Target Target CA 50 1,293 121 0.03 -0.95 0.09 0.69
Myeloperoxidase 16,181 Target Drug Kaempferitrin 32 3 0.00 -0.95 0.09 0.64
CD14 9,941 Target Target Toll-Like Receptor 2 2,174 204 0.04 -0.94 0.09 0.73
Collagen 138,882 Target Target BMP-4 1,255 118 0.01 -0.95 0.09 0.61
CAPG 85 Target Disease Breast Cancer 173,695 8 0.00 -0.95 0.09 0.58
EPHB4 329 Target Target EPHB1 137 13 0.06 -0.93 0.09 0.81
CAMK2A 42 Target Target CAMK2B 21 2 0.07 -0.93 0.10 0.83
CAMK1D 21 Target Disease Breast Cancer 173,695 2 0.00 -0.95 0.10 0.57
CAMK2D 21 Target Disease Epilepsy 71,172 2 0.00 -0.95 0.10 0.59
CAMK2D 21 Target Disease Seizures 66,465 2 0.00 -0.95 0.10 0.60
Cytokeratin 8 587 Target Disease Breast Cancer 173,695 56 0.01 -0.95 0.10 0.60
AKT3 293 Target Disease Breast Cancer 173,695 28 0.00 -0.95 0.10 0.59